DK123596B - Analogifremgangsmåde til fremstilling af 2α,3α-epithio-17β-hydroxy-Δ6-5α-androsten eller derivater deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 2α,3α-epithio-17β-hydroxy-Δ6-5α-androsten eller derivater deraf.

Info

Publication number
DK123596B
DK123596B DK512468AA DK512468A DK123596B DK 123596 B DK123596 B DK 123596B DK 512468A A DK512468A A DK 512468AA DK 512468 A DK512468 A DK 512468A DK 123596 B DK123596 B DK 123596B
Authority
DK
Denmark
Prior art keywords
epithio
androstene
hydroxy
derivatives
preparation
Prior art date
Application number
DK512468AA
Other languages
English (en)
Inventor
T Komeno
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK123596B publication Critical patent/DK123596B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01L—MEASURING FORCE, STRESS, TORQUE, WORK, MECHANICAL POWER, MECHANICAL EFFICIENCY, OR FLUID PRESSURE
    • G01L11/00—Measuring steady or quasi-steady pressure of a fluid or a fluent solid material by means not provided for in group G01L7/00 or G01L9/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Steroid Compounds (AREA)
DK512468AA 1967-10-25 1968-10-24 Analogifremgangsmåde til fremstilling af 2α,3α-epithio-17β-hydroxy-Δ6-5α-androsten eller derivater deraf. DK123596B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6868267 1967-10-25

Publications (1)

Publication Number Publication Date
DK123596B true DK123596B (da) 1972-07-10

Family

ID=13380728

Family Applications (1)

Application Number Title Priority Date Filing Date
DK512468AA DK123596B (da) 1967-10-25 1968-10-24 Analogifremgangsmåde til fremstilling af 2α,3α-epithio-17β-hydroxy-Δ6-5α-androsten eller derivater deraf.

Country Status (6)

Country Link
US (2) US3657225A (da)
DE (1) DE1805338A1 (da)
DK (1) DK123596B (da)
FR (1) FR8462M (da)
GB (1) GB1253828A (da)
NL (1) NL6815270A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2558076C2 (de) * 1975-12-19 1983-12-15 Schering AG, 1000 Berlin und 4709 Bergkamen Depot-Steroidester, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
US3749778A (en) 1973-07-31
FR8462M (da) 1972-01-07
GB1253828A (en) 1971-11-17
US3657225A (en) 1972-04-18
DE1805338A1 (de) 1969-10-16
NL6815270A (da) 1969-04-29

Similar Documents

Publication Publication Date Title
DK137988B (da) Analogifremgangsmåde til fremstilling af isothiocyano-benzazoler eller salte deraf.
DK118820B (da) Analogifremgangsmåde til fremstilling af derivater af 5-nitro-2-furyl-isoxazoliner.
DK124265B (da) Analogifremgangsmåde til fremstilling af cephalosporanderivater eller α-karbonylderivater eller salte deraf eller af α-karbonylderivaterne.
DK111896B (da) Fremgangsmåde til fremstilling af methylendioxybenzen eller 1,3-benzoxathiol eller derivater deraf.
DK123868B (da) Analogifremgangsmåde til fremstilling af 3-hydroxycumarin-derivater.
DK118507B (da) Fremgangsmåde til fremstilling af 3-dimethylsulfamoylphenthiazinderivater.
DK125890B (da) Analogifremgangsmåde til fremstilling af pyrazolderivater eller salte deraf.
DK128811B (da) Analogifremgangsmåde til fremstilling af 14α,17α-methylendioxypregnanderivater.
DK119166B (da) Fremgangsmåde til fremstilling af 1,4-bezodiazepinderivater.
DK119559B (da) Analogifremgangsmåde til fremstilling af 4-pyrimidyl-1,4-dihydropyridinderivater.
DK119609B (da) Analogifremgangsmåde til fremstilling af 2α,2β, 17α-trimethyl-13β-alkylgona-4,9,11-trien-17β-oler.
DK121054B (da) Analogifremgangsmåde til fremstilling af spiro-azatetramethylenderivater eller salte deraf.
DK118291B (da) Analogifremgangsmåde til fremstilling af 10α-alkoxy-9,10-dihydroergolinderivater.
DK126112B (da) Analogifremgangsmåde til fremstilling af 22-amino-23,24-dinorkolanderivater eller salte deraf.
DK123596B (da) Analogifremgangsmåde til fremstilling af 2α,3α-epithio-17β-hydroxy-Δ6-5α-androsten eller derivater deraf.
DK130307B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkyl-17β-hydroxy-17α-ethynylgona-4,9-diener.
DK124882B (da) Analogifremgangsmåde til fremstilling af 17α-acyloxy-11β-methyl-19-norpregn-4-en-3,20-dioner.
DK124205B (da) Analogifremgangsmåde til fremstilling af 6-klor-4-metylamino-1H-2,3-benzoxazin.
DK120994B (da) Analogifremgangsmåde til fremstilling af N,N-dimethylaminoætyl-14β-hydroksy-5β-pregn-20-en-21-karboksylater.
DK129842B (da) Fremgangsmåde til fremstilling af 3-imino-1,2-benzisothiazoliner.
DK121372B (da) Analogifremgangsmåde til fremstilling af 17β-(1-alkoxycycloalkyloxy)-2α,3α-epithio-5α-androstaner.
DK120029B (da) Analogifremgangsmåde til fremstilling af substituerede 3-aminoacylaminothiophener eller salte deraf.
DK128456B (da) Analogifremgangsmåde til fremstilling af ketonreduceret dihydrotyløsin eller ketonreduceret dihydrodesmycosin.
DK109871C (da) Fremgangsmåde til fremstilling af 2-aminometyl-3,4-dihydro-2H-pyraner eller derivater deraf.
DK119012B (da) Analogifremgangsmåde til fremstilling af thebainderivater.